Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines. 2008

Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
Departamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, c/Campus de Cartuja s/n, 18071 Granada, Spain.

A series of eleven 2- and 6-substituted (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purine derivatives was obtained by applying a standard Mitsunobu protocol that led to a six-membered ring contraction from (R,S)-3,4-dihydro-2H-1,5-benzoxathiepin-3-ol via an episulfonium intermediate. The signal approximately delta=151 ppm, which corresponds to the C4' carbon atom, is unequivocal proof of the N9' regioisomer. The potential of the target molecules as anticancer agents is reflected in their activity against the MCF-7 cancer cell line. The most active compounds have IC(50) values of (6.18+/-1.70) and (8.97+/-0.83) microM. The results indicate that the anticancer activity for the most active compounds is correlated with their capacity to induce apoptosis.

UI MeSH Term Description Entries
D009584 Nitrogen An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
D010075 Oxathiins Oxathins
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
September 2011, European journal of medicinal chemistry,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
August 2008, European journal of medicinal chemistry,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
April 1995, Bioorganic & medicinal chemistry,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
January 1991, Journal of medicinal chemistry,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
August 2008, Acta crystallographica. Section E, Structure reports online,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
April 2024, ChemMedChem,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
November 2003, Bioorganic & medicinal chemistry,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
August 1989, Journal of medicinal chemistry,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
January 2014, International journal of microbiology,
Mónica Díaz-Gavilán, and Ana Conejo-García, and Olga Cruz-López, and María C Núñez, and Duane Choquesillo-Lazarte, and Josefa M González-Pérez, and Fernando Rodríguez-Serrano, and Juan A Marchal, and Antonia Aránega, and Miguel A Gallo, and Antonio Espinosa, and Joaquín M Campos
October 1988, Journal of medicinal chemistry,
Copied contents to your clipboard!